Non-Current Assets
Other Non-Current Assets
AbbVie Other Non-Current Assets increased by 11.2% to $10.72B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 17.3%, from $9.14B to $10.72B. Over 5 years (FY 2020 to FY 2025), Other Non-Current Assets shows an upward trend with a 17.2% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryOther
SignalContext dependent
VolatilityStable
First reportedQ3 2015
Last reportedQ4 2025
How to read this metric
Large fluctuations may relate to changes in long-term investment strategy or tax accounting adjustments.
Detailed definition
A catch-all category for long-term assets that do not fit into major classifications like PPE or Intangibles. This may i...
Peer comparison
Often contains strategic minority investments in technology partners or long-term tax-related items.
Metric ID:
other_non_current_assetsHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.81B | $4.75B | $4.88B | $5.08B | $5.03B | $5.38B | $5.57B | $5.80B | $6.20B | $7.09B | $8.51B | $9.07B | $9.20B | $8.29B | $9.14B | $9.19B | $9.66B | $9.64B | $10.72B |
| QoQ Change | — | -1.3% | +2.9% | +4.1% | -1.0% | +6.9% | +3.5% | +4.1% | +6.9% | +14.5% | +20.0% | +6.5% | +1.4% | -9.9% | +10.3% | +0.5% | +5.1% | -0.2% | +11.2% |
| YoY Change | — | — | — | — | +4.7% | +13.4% | +14.1% | +14.1% | +23.1% | +31.8% | +52.8% | +56.3% | +48.4% | +16.8% | +7.4% | +1.4% | +5.0% | +16.4% | +17.3% |
Range$4.75B – $10.72B
CAGR+19.5%
Avg YoY Growth+21.5%
Median YoY Growth+16.4%
Other Non-Current Assets at Other Companies
Frequently Asked Questions
- What is AbbVie's other non-current assets?
- AbbVie (ABBV) reported other non-current assets of $10.72B in Q4 2025.
- How has AbbVie's other non-current assets changed year-over-year?
- AbbVie's other non-current assets increased by 17.3% year-over-year, from $9.14B to $10.72B.
- What is the long-term trend for AbbVie's other non-current assets?
- Over 5 years (2020 to 2025), AbbVie's other non-current assets has grown at a 17.2% compound annual growth rate (CAGR), from $4.85B to $10.72B.
- What does other non-current assets mean?
- Miscellaneous long-term investments and assets that the company plans to hold for more than a year.